2Where the lesion sits
Before cataloguing causes, it helps to have a map of where on the auditory pathway a cause can strike. Hearing can fail in four broad places — the conductive apparatus, the sensory hair cells, the neural elements, and the central pathway — and the word 'sensorineural' deliberately fuses two of them. That fusion is convenient for audiometry but dangerous for prognosis, because the cochlear implant treats the sensory failure brilliantly and the neural failure only partly. This short module sets up the coordinate system the rest of the chapter uses: for every cause, the question is which of these zones it injures, and whether the implant's entry point lies above or below the damage.
FFour places hearing can fail
Trace the path of sound and there are four broad sites where it can break down. A conductive lesion in the outer or middle ear stops sound reaching a healthy cochlea — usually treatable, and not implant territory. A sensory lesion destroys the hair cells of the organ of Corti. A neural lesion damages the spiral-ganglion neurons or the auditory nerve. And a central lesion lies above the nerve, in the brainstem or cortex. The same degree of hearing loss can come from any of them.
FTSensorineural — two zones, one label
The term sensorineural bundles the sensory and the neural together, because the routine audiogram cannot separate them: both produce a loss with no air–bone gap. But biologically they are different. A pure sensory loss — dead hair cells over a living nerve — is the textbook implant case. A neural loss damages the very cells the implant must stimulate. One label, two prospects.
TWhere the implant enters
The reason the distinction is not academic is the implant's point of entry. A cochlear implant injects its signal at the spiral ganglion, downstream of the hair cells and upstream of the brainstem. Everything between the eardrum and the ganglion — the middle ear, the cochlear fluids, the hair cells — is simply bypassed. That is why a sensory lesion is no obstacle. But the ganglion itself, the nerve, and the central pathway are not bypassed; if the lesion sits there, the implant cannot route around it.
CWhy the distinction decides outcome
This single geometric fact — entry at the ganglion — organises every cause that follows. As we go through them, the recurring question is the same: does this disease damage the cochlea (which the implant bypasses) or the neural elements (which it depends on), or both? Causes that stay upstream tend to implant well; causes that reach the ganglion or nerve are the hard cases. The chapter is, in effect, a tour of where each disease lands on the spectrum you have just seen.
How should the site of lesion guide the answer?
At what point does a cochlear implant inject its signal into the auditory pathway?
Why can the single label 'sensorineural' hide two very different prospects for implantation?